Bayoomed is a Germany-based startup dedicated to engineering Medical Software. With a founding date of 2021, the company has swiftly established itself as a leading player in the industry. Operating as the medical software branch of BAYOONET Group, Bayoomed has accumulated almost a decade of project experience in developing medical software, including embedded, desktop, web, and cloud-based solutions, as well as medical apps. The company prides itself on being one of the most experienced medical software developers in Europe, catering to a client base of over 800 customers within the healthcare sector. Moreover, Bayoomed’s commitment to an agile development approach has proved beneficial for its clients, with a focus on areas such as embedded software, cloud-based healthcare solutions, mobile medical and healthcare apps, and Digital Healthcare Applications (DiGA). Although details about the last investment and the investors involved are not available at this time, Bayoomed's strong foothold in the market and its specialization in regulated medical and pharmaceutical environments make it an intriguing prospect for potential venture capital interest. Investors seeking to capitalize on the burgeoning medical software sector would be well-served to keep a close eye on Bayoomed's future endeavors.
There is no investment information
No recent news or press coverage available for BAYOOMED.